Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

High Throughput Screening of Infectious Virus Entry in Mammalian Cells

Published: Thursday, June 07, 2007
Last Updated: Thursday, June 07, 2007
Bookmark and Share
Researchers at Swiss Federal Institute of Technology are using two customized Tecan Freedom EVO® 200 liquid handling workstations to silence 7,000 mammalian genes.

Researchers at the Institute of Molecular Systems Biology (IMSB), Swiss Federal Institute of Technology (ETH), Zurich, Switzerland, are using two customized Tecan Freedom EVO® 200 liquid handling workstations as part of a study to identify the specific sets of host genes that viruses depend on to infect cells.

The large-scale, genome-wide study aims to individually silence 7,000 mammalian genes using RNA interference (RNAi), and measure how each silencing affects the abilities of 11 different viruses, including influenza, herpes and SV40, to infect mammalian hosts.

The automated set-up is critical to the project, as analyzing the effects of silencing 7,000 genes on one virus requires 207 384-well plates and takes about two weeks to complete.

One Freedom EVO workstation is equipped with a Te-MO™ 384-channel pipetting head to perform all the transfection and infection assays. The second workstation has a Te-Stack™ stacker module and two fully integrated Cell-Works microscopes for automated quantification of the proportion of virus-transfected cells.

Dr Pelkmans, assistant professor at the IMSB, explained: “The project is providing valuable information about how viruses hijack endocytic pathways for host entry and, potentially, could lead to the development of novel anti-viral therapies targeted against host cellular genes instead of viral components. We have already seen some very exciting results.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Tecan Provides Automated Solutions for Molecular Pharmacology
Leibniz-Institut uses Tecan’s Freedom EVO® workstations for systematic high throughput screening of bioactive small molecule libraries.
Tuesday, July 06, 2010
Screening Center Chooses Tecan for Reliability and Support
The University of Chicago’s CSC is using Tecan’s Freedom EVO® workstations to provide high throughput cell screening services.
Friday, June 11, 2010
Tecan Platforms Improve Microarray Throughput and Research Quality in South Africa
South African researchers have established a high throughput biological research platform with a number of automated microarray processing systems from Tecan.
Friday, February 22, 2008
Tecan Boosts RNA Work in France
Tecan's Freedom EVO® Workstation has been used to develop automated in vitro selection techniques for identifying and isolating aptamers.
Wednesday, March 29, 2006
Scientific News
Unravelling the Metastatic Mechanism of Melanoma
Research has uncovered the mechanism of melanoma spreading; the findings could lead to a cure for the disease.
Gene Therapy Via Ultrasound
Research into a gene therapy approach called sonoporation could help combat heart disease and cancer.
Novel MRI Technique Distinguishes Healthy Prostate Tissue from Cancer
The UTSW researchers have determined that glucose stimulates release of the zinc ions from inside epithelial cells, which they could then track on MRIs.
Precision Nanobots Target Cancerous Tumours
Researchers achieve breakthrough toward redefining anti-cancer drug administration using nanorobotics.
PARP Proteins Explore Therapeutic Targets in Cancer
Researchers at UTSW have identified a previously unknown role of a certain class of proteins that opens the door to explore therapeutic targets in cancer and other disease.
Novel Therapeutic Approach for Blood Disorders
Gene editing of human blood-forming stem cells mimics a benign genetic condition that helps to overcome sickle cell disease and other blood disorders.
Immune-Cell Population Predicts Immunotherapy Response in Melanoma
All patients with high levels of one immune-cell type responded to treatment.
Effects of Chemotherapy on Developing Ovaries in Female Fetuses
Researchers at University of Edinburgh have shown that etoposide can damage the development of the ovaries while a fetus is in the womb.
Breast Tumors Evolve in Response to Hormone Therapy
Researchers have suggested that analyzing a single sample of the breast tumor is insufficient for understanding how a patient should best be treated.
Cutting off the Cancer Fuel Supply
Research from investigators at Rutgers Cancer Institute of New Jersey and Princeton University has identified a new approach to cancer therapy in cutting off a cancer cell’s ‘fuel supply’ by targeting a cellular survival mechanism known as autophagy. The co-corresponding authors of the work are Rutgers Cancer Institute Deputy Director Eileen P. White, PhD, and researcher ‘Jessie’ Yanxiang Guo, PhD.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!